Skip to content
Screener

Viatris VTRS Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue$3.6BBeat by $115.1M
EPS$0.62Beat by $0.06
Revenue estimate$3.5B
EPS estimate$0.56

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$3.8B
EPS estimate$0.67

Financials

Q2 2025

Income statement

See full
Revenue$3.6B-5.6%
Gross profit$1.3B-7.8%
Operating income$233.0M+197%
Net income-$4.6M+98.6%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$567.8M-38.2%
Total debt$14.8B-15.0%
Total equity$15.6B-20.2%
Total assets$38.4B-15.3%

Cash flow

See full
Operating cash flow$219.7M-42.0%
CapEx$52.9M-10.0%
Free cash flow$166.8M-47.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$10.5B-17.3%
Enterprise value$24.7B-15.3%
P/S0.7×-0.1×

Profitability

See full
Gross margin36.6%-4.3pp
Net margin-24.6%—
FCF margin12.4%-0.9pp

Returns & leverage

See full
Return on equity-19.8%—
Debt / equity0.9×+0.1×
Current ratio1.4×-0.2×

Segments

By product

See full
Brands$2.3B-3.3%
Generics$1.3B-9.7%
Lipitor$387.9M+11.3%
Norvasc$182.7M+12.8%
EpiPen® Auto-Injectors$136.8M+18.4%

By segment

See full
Developed Markets Segment$2.1B—
Greater China$588.9M+9.2%
Emerging Markets Segment$556.9M-4.4%
Japan, Australia and New Zealand Segment$306.7M-12.3%

FAQ

When did Viatris report Q2 2025 earnings?
Viatris (VTRS) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Viatris's Q2 2025 revenue and EPS?
Viatris reported revenue of $3.6B and eps of $0.62 for Q2 2025.
Did Viatris beat estimates in Q2 2025?
Revenue beat the consensus estimate of $3.5B by $115.1M. EPS beat the consensus estimate of $0.56 by $0.06.
How did Viatris's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 5.6% from $3.8B a year earlier and eps declined 10.1% from $0.69.
Where can I find Viatris's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-028739) and the 10-Q periodic report (0001792044-25-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.